功能性单心室合并右同构患者心血管手术后死亡的危险因素
该回顾性研究分析了1979至2020年间129例功能性单心室合并右同构患者的资料,按首次姑息手术年代分为两组。结果示10年生存率从时代1的36.4%升至时代2的57.8%,差异显著(P=0.0268),Fontan完成率也显著改善(P=0.0392)。多变量分析中首次姑息手术日期是死亡的唯一预测因素。
要点
- 10年生存率时代1为36.4%,时代2为57.8%,差异显著(P=0.0268)。
- Fontan完成率时代1为22/59,时代2为38/66,差异显著(P=0.0392)。
- 多变量分析中首次姑息手术日期是死亡的唯一预测因素。
核心结论
- 功能性单心室合并右同构患者心血管手术后死亡率在过去20年有所改善,但仍较高;此改善可能归因于当前的手术策略和临床管理,但需进一步研究证实。
研究设计与样本
- 回顾性审查1979至2020年在静冈儿童医院(Mt. Fuji Shizuoka Children's Hospital)连续接受肺血流控制手术的129例功能性单心室合并右同构患者的医疗记录,按首次姑息手术日期分为时代1(1979-1999)和时代2(2000-2020)两组。
主要发现
- 10年估计生存率时代1为36.4%,时代2为57.8%,两时代间生存率改善显著(P=0.0268)。
- Fontan手术完成率时代1为22/59,时代2为38/66,当前时代显著更优(P=0.0392)。
- 多变量分析中,首次姑息手术日期是死亡的唯一预测因素。
局限性
- 原文结论指出需要进一步研究来证实当前手术策略和临床管理对死亡率改善的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Cardiac malformations are a major component of heterotaxy syndrome that results in significant mortality and morbidity, especially in patients with a single ventricle and right isomerism (RI). The goal of this study was to evaluate the mortality after cardiovascular surgery in patients with a functional single ventricle and RI over a long follow-up period (∼40 years) and to determine the predicted risk factors for mortality. METHODS: We performed a retrospective review of the medical records of 129 consecutive patients with functional single ventricle and RI who underwent pulmonary flow control operations at Mt. Fuji Shizuoka Children's Hospital between 1979 and 2020. To evaluate mortality rates, the patients were divided into 2 groups (era 1: 1979-1999 and era 2: 2000-2020) based on the date of the first-stage palliation. RESULTS: The estimated survival rate at 10 years was 36.4% in era 1 and 57.8% in era 2. The estimated survival rate improved significantly (P = 0.0268) between the 2 eras. The rate of Fontan procedure completion was also significantly better in the current era (P = 0.0392; 22/59 in era 1 and 38/66 in era 2). In the multivariable analysis, the date of the first-stage palliation was the only predictor of mortality. CONCLUSIONS: The mortality rate after cardiovascular surgery in patients with a functional single ventricle and RI has improved over the past 20 years; however, it still remains high. This improvement may be attributed to our current surgical strategy and clinical management; however, further investigations are needed to prove this observation.
引用
- Hirose K, Ikai A, Ito H, et al. Risk factors for mortality after cardiovascular surgery in patients with functional single ventricle and right isomerism. Eur J Cardiothorac Surg. 2022. PMID: 35147681. doi:10.1093/ejcts/ezac080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。